Allakos

Develop therapeutic antibodies for the treatment of allergic, inflammatory, and proliferative diseases

placeSan Mateo, California, United States calendar_todayFounded 2012 groups123 employees language allakos.com

Registered entities

Innovation

23 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,842 times.

YearFilings
20152
20163
20173
20188
201910
202010
202111
202212
202311
202411
20255

Investor mix

14 investors on record; lead investors include New Enterprise Associates, RiverVest Venture Partners, Alta Partners, Roche; 1 has since exited.

Investor typeCountShare
Venture capital964%
Private equity17%
Other / undisclosed429%
Coming soon